Fresenius Medical Care Stock Performance
| FMCQF Stock | USD 49.25 0.13 0.26% |
The firm shows a Beta (market volatility) of -0.23, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Fresenius Medical are expected to decrease at a much lower rate. During the bear market, Fresenius Medical is likely to outperform the market. At this point, Fresenius Medical Care has a negative expected return of -0.0185%. Please make sure to confirm Fresenius Medical's potential upside, and the relationship between the information ratio and rate of daily change , to decide if Fresenius Medical Care performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Fresenius Medical Care has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Fresenius Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 1.1 B | |
| Total Cashflows From Investing Activities | -1.2 B |
Fresenius |
Fresenius Medical Relative Risk vs. Return Landscape
If you would invest 5,100 in Fresenius Medical Care on August 17, 2025 and sell it today you would lose (175.00) from holding Fresenius Medical Care or give up 3.43% of portfolio value over 90 days. Fresenius Medical Care is currently producing negative expected returns and takes up 2.6241% volatility of returns over 90 trading days. Put another way, 23% of traded pink sheets are less volatile than Fresenius, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Fresenius Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fresenius Medical's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Fresenius Medical Care, and traders can use it to determine the average amount a Fresenius Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0071
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FMCQF |
Estimated Market Risk
| 2.62 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Fresenius Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fresenius Medical by adding Fresenius Medical to a well-diversified portfolio.
Fresenius Medical Fundamentals Growth
Fresenius Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Fresenius Medical, and Fresenius Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Fresenius Pink Sheet performance.
| Return On Equity | 0.0666 | |||
| Return On Asset | 0.0253 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 22.64 B | |||
| Shares Outstanding | 293.41 M | |||
| Price To Earning | 11.60 X | |||
| Price To Book | 0.58 X | |||
| Price To Sales | 0.49 X | |||
| Revenue | 17.62 B | |||
| EBITDA | 1.93 B | |||
| Cash And Equivalents | 1.11 B | |||
| Cash Per Share | 3.07 X | |||
| Total Debt | 6.65 B | |||
| Debt To Equity | 0.82 % | |||
| Book Value Per Share | 41.54 X | |||
| Cash Flow From Operations | 2.49 B | |||
| Earnings Per Share | 2.79 X | |||
| Total Asset | 34.37 B | |||
| Retained Earnings | 8.45 B | |||
| Current Asset | 7.22 B | |||
| Current Liabilities | 5.25 B | |||
About Fresenius Medical Performance
By analyzing Fresenius Medical's fundamental ratios, stakeholders can gain valuable insights into Fresenius Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Fresenius Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Fresenius Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Med is traded on OTC Exchange in the United States.Things to note about Fresenius Medical Care performance evaluation
Checking the ongoing alerts about Fresenius Medical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Fresenius Medical Care help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Fresenius Medical generated a negative expected return over the last 90 days | |
| About 32.0% of the company shares are held by company insiders |
- Analyzing Fresenius Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Fresenius Medical's stock is overvalued or undervalued compared to its peers.
- Examining Fresenius Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Fresenius Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Fresenius Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Fresenius Medical's pink sheet. These opinions can provide insight into Fresenius Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Fresenius Pink Sheet analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |